Cargando…

Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease

BACKGROUND: Frequent exacerbations induce a high burden to Chronic Obstructive Pulmonary Disease (COPD). We investigated the course of exacerbations in the published COSMIC study that investigated the effects of 1-year withdrawal of fluticasone after a 3-month run-in treatment period with salmeterol...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Berge, Maarten, Hop, Wim CJ, van der Molen, Thys, van Noord, Jan A, Creemers, Jacques PHM, Schreurs, Ad JM, Wouters, Emiel FM, Postma, Dirkje S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494574/ https://www.ncbi.nlm.nih.gov/pubmed/22672621 http://dx.doi.org/10.1186/1465-9921-13-44

Ejemplares similares

Development of a tool to recognize small airways dysfunction in asthma (SADT)
por: Schiphof-Godart, Lieke, et al.
Publicado: (2014)

COPD exacerbations in general practice: variability in oral prednisolone courses
por: de Vries, Marianne, et al.
Publicado: (2012)

Fentanyl nasal spray in a patient with end-stage COPD and severe chronic breathlessness
por: Janssen, Daisy J.A., et al.
Publicado: (2019)

A self-rating scale for patient-perceived side effects of inhaled corticosteroids
por: Foster, Juliet M, et al.
Publicado: (2006)

Development, validity and responsiveness of the Clinical COPD Questionnaire
por: van der Molen, Thys, et al.
Publicado: (2003)

Airways inflammation and treatment during acute exacerbations of COPD
por: Bathoorn, Erik, et al.
Publicado: (2008)

Impact of multiple-dose versus single-dose inhaler devices on COPD patients’ persistence with long-acting β(2)-agonists: a dispensing database analysis
por: van Boven, Job FM, et al.
Publicado: (2014)

COPD-Lower Respiratory Tract Infection Visual Analogue Score (c-LRTI-VAS) validation in stable and exacerbated patients with COPD
por: Prins, Hendrik Johannes, et al.
Publicado: (2021)

Primary Care Management of Asthma Exacerbations or Attacks: Impact of the COVID-19 Pandemic
por: Fletcher, Monica, et al.
Publicado: (2022)

Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation
por: Bathoorn, Erik, et al.
Publicado: (2009)

Towards tailored and targeted adherence assessment to optimise asthma management
por: van Boven, Job FM, et al.
Publicado: (2015)

Inflammation and corticosteroid responsiveness in ex-, current- and never-smoking asthmatics
por: Telenga, Eef D, et al.
Publicado: (2013)

Predictors of cost-effectiveness of selected COPD treatments in primary care: UNLOCK study protocol
por: van Boven, Job F M, et al.
Publicado: (2015)

Neonatal Procalcitonin Intervention Study (NeoPInS): Effect of Procalcitonin-guided decision making on Duration of antibiotic Therapy in suspected neonatal early-onset Sepsis: A multi-centre randomized superiority and non-inferiority Intervention Study
por: Stocker, Martin, et al.
Publicado: (2010)

Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
por: Oshagbemi, Olorunfemi A., et al.
Publicado: (2018)

Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands
por: van der Molen, Thys, et al.
Publicado: (2016)

Erratum to: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands
por: van der Molen, Thys, et al.
Publicado: (2016)

Physical, Psychological, and Social Factors Associated with Exacerbation-Related Hospitalization in Patients with COPD
por: Crutsen, Mieke R.C., et al.
Publicado: (2020)

Airway wall thickness on HRCT scans decreases with age and increases with smoking
por: Telenga, Eef D., et al.
Publicado: (2017)

Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care
por: Bathoorn, Erik, et al.
Publicado: (2017)

Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease
por: Kocks, Jan Willem H, et al.
Publicado: (2013)

Identification of transforming growth factor-beta-regulated microRNAs and the microRNA-targetomes in primary lung fibroblasts
por: Ong, Jennie, et al.
Publicado: (2017)

Susceptibility to COPD: Differential Proteomic Profiling after Acute Smoking
por: Franciosi, Lorenza, et al.
Publicado: (2014)

Airway gene expression in COPD is dynamic with inhaled corticosteroid treatment and reflects biological pathways associated with disease activity
por: van den Berge, Maarten, et al.
Publicado: (2014)

A systematic review of the role of vitamin insufficiencies and supplementation in COPD
por: Tsiligianni, Ioanna G, et al.
Publicado: (2010)

Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids
por: Postma, Dirkje S., et al.
Publicado: (2017)

Level and course of FEV(1 )in relation to polymorphisms in NFE2L2 and KEAP1 in the general population
por: Siedlinski, Mateusz, et al.
Publicado: (2009)

A score to predict short-term risk of COPD exacerbations (SCOPEX)
por: Make, Barry J, et al.
Publicado: (2015)

Tumor Necrosis Factor-α +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease
por: Küçükaycan, Mehmet, et al.
Publicado: (2002)

Skin autofluorescence: early sign of lung function deterioration?
por: Wouters, Emiel F.M., et al.
Publicado: (2020)

Organizational aspects of pulmonary rehabilitation in chronic respiratory diseases
por: Spruit, Martijn A., et al.
Publicado: (2019)

Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease
por: Jenkins, Christine R., et al.
Publicado: (2015)

Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey
por: Price, David, et al.
Publicado: (2014)

The efficacy and safety of inhaled corticosteroids: are we ignoring the potential advantages of ciclesonide?
por: van der Molen, Thys, et al.
Publicado: (2014)

Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands
por: van Boven, Job FM, et al.
Publicado: (2016)

Glutathione S-transferases and their implications in the lung diseases asthma and chronic obstructive pulmonary disease: Early life susceptibility?
por: van de Wetering, Cheryl, et al.
Publicado: (2021)

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials
por: Eriksson, Göran, et al.
Publicado: (2017)

Integrated proteogenomic approach identifying a protein signature of COPD and a new splice variant of SORBS1
por: Brandsma, Corry-Anke, et al.
Publicado: (2020)

Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease
por: Jones, Paul W, et al.
Publicado: (2011)

COPD management: role of symptom assessment in routine clinical practice
por: van der Molen, Thys, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_p1vjqgqk1oe7flkf7gf6r5003g